Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...
London, July 1, 2024: The Drug Repurposing & Repositioning Inventions Boardroom provided a deep dive on this important topic with industry experts from NLO, 3D-PharmXchange, and the Repo4EU consortium ...
The premise is straightforward — we are awash in biological data. The rapid growth of multiomics datasets (genomics, transcriptomics, proteomics, metabolomics, and radiomics) together with ...
Universities and hospitals are repurposing existing drugs through late-stage trials with funded costs up to 90% lower than those in the pharmaceutical industry. This "hidden" research system, which ...
Officials from nonprofit organizations, along with a former high-ranking US Food and Drug Administration (FDA) official, are considering mechanism to encouraging nonprofits to repurpose existing ...
The U.S. Food and Drug Administration (FDA) recently launched a drug repurposing initiative that may signal a shift in how ...
Every Cure is using AI to seek new uses for the roughly 4,000 existing drugs, and cutting traditional preliminary research timelines from as much as 100 days to as little as 17 hours. Treatment for a ...
Repurposing existing drugs is an alluring way to develop new treatments because it relies on medicines that have been studied, have well-understood safety profiles, and have gone through the ...
Drug repurposing holds immense promise when approached deliberately rather than as a fortunate accident, as Christopher Snyder and Sarrin Chethik argue in “You Can Teach an Old Drug New Tricks” (op-ed ...
The US Food and Drug Administration (FDA) is asking for input on repurposing older drugs for new therapeutic uses to address unmet medical needs across a wide range of therapeutic areas. FDA said that ...
Drug repurposing — the identification of new therapeutic indications for approved drugs or clinical-stage candidates — offers one of the most efficient strategies to deliver new treatments to patients ...